A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/27/2011	US8084464 Tetrahydroisoquinoline derivatives
12/27/2011	US8084463 Quinuclidine derivatives and their use as muscarinic M3 receptor antagonists
12/27/2011	US8084462 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
12/27/2011	US8084461 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
12/27/2011	US8084460 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
12/27/2011	US8084459 Substituted quinazolinones for treating neurological conditions
12/27/2011	US8084456 Pyrazine-based tubulin inhibitors
12/27/2011	US8084455 Use of a kinase inhibitor for the treatment of particular resistant tumors
12/27/2011	US8084454 Compounds with anti-cancer activity
12/27/2011	US8084453 Alkyl substituted indoloquinoxalines
12/27/2011	US8084452 Substituted enaminocarbonyl compounds used as insecticides
12/27/2011	US8084451 Heteropyrrole analogs acting on cannabinoid receptors
12/27/2011	US8084450 Organic compounds
12/27/2011	US8084449 Dual pharmacophores—PDE4-muscarinic antagonistics
12/27/2011	US8084448 Organic compounds
12/27/2011	US8084447 Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use
12/27/2011	US8084446 Use of DHEA derivatives for enhancing physical performance
12/27/2011	US8084445 Pharmaceutical formulation
12/27/2011	US8084444 Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations
12/27/2011	US8084443 Biological specimen collection and transport system and methods of use
12/27/2011	US8084442 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
12/27/2011	US8084441 Cystitis treatment with high dose chondroitin sulfate
12/27/2011	US8084440 Administering to a vertebrate animal in need of improved fertility a composition comprising 0.004-40 milligram of indole-3-acetic acid per kilogram life weight of the vertebrate animal per day; composition additionally may comprise beta glucans
12/27/2011	US8084439 Methods for identifying compounds for the treatment of type 1 diabetes
12/27/2011	US8084437 Methods for treating hypercholesterolemia
12/27/2011	US8084436 Modulation of SGLT2 expression
12/27/2011	US8084435 Biodegradable linkers for molecular therapies
12/27/2011	US8084434 Using modulators which alter protein DNA binding as tool in prevention and treatment of cell proliferative disorders
12/27/2011	US8084432 Compositions and methods for treatment of pouchitis
12/27/2011	US8084431 Method for inhibiting activation of macrophages, inhibiting formation of osteoclasts, inhibiting function of osteoclasts, and/or activating osteoblasts
12/27/2011	US8084430 ENT-kaurene diterpene compound and its derivatives, their preparation and their use
12/27/2011	US8084420 Rapid acting and long acting insulin combination formulations
12/27/2011	US8084210 Methods for the assessment of drug response
12/27/2011	US8084067 Phospholipid complexes of olive fruits extracts having improved bioavailability
12/27/2011	US8084059 Antidepressant dosage form
12/27/2011	US8084058 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
12/27/2011	US8084054 Bioerodible film for ophthalmic drug delivery
12/27/2011	US8084052 Chemical composition for controlling insects
12/27/2011	US8084049 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
12/27/2011	US8084047 Compositions and methods for treatment of eye disorders
12/27/2011	US8084042 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines
12/27/2011	US8084015 Immunostimulatory complex of a cationic peptide immunogen and anionic CpG single-stranded DNA oligonucleotide
12/23/2011	CA2744428A1 Nutritional or dietary supplement composition and methods for using same for treating visual acuity loss
12/22/2011	WO2011160136A2 Progesterone containing oral dosage forms and related methods
12/22/2011	WO2011160093A2 Methods and systems for modulating hormones and related methods, agents and compositions
12/22/2011	WO2011160084A1 D2 antagonists, methods of synthesis and methods of use
12/22/2011	WO2011160020A2 Carbapenem antibacterials with gram-negative activity
12/22/2011	WO2011159974A2 TARGETING THE ALPHA3 SUBUNIT OF Na+K+-ATPase FOR THE TREATMENT OF COUGH WITH SULFENAMIDES
12/22/2011	WO2011159951A2 Targeting tumor associated macrophages using bisphosphonate-loaded particles
12/22/2011	WO2011159945A2 Methods for treating neurological conditions
12/22/2011	WO2011159926A1 Antimicrobial agents
12/22/2011	WO2011159920A1 [5,6]-dihydro-2h-pyran-2-one derivatives
12/22/2011	WO2011159903A2 Asenapine maleate
12/22/2011	WO2011159871A2 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
12/22/2011	WO2011159870A1 Methods and compounds for the preparation of fluorine-labeled deoxy-fty720
12/22/2011	WO2011159864A1 Jte013 analogs and methods of making and using same
12/22/2011	WO2011159857A1 Carboline carboxamide compounds useful as kinase inhibitors
12/22/2011	WO2011159854A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	WO2011159852A1 Piperidinyl compound as a modulator of chemokine receptor activity
12/22/2011	WO2011159840A2 Phenylthioacetate compounds, compositions and methods of use
12/22/2011	WO2011159839A2 Thioacetate compounds, compositions and methods of use
12/22/2011	WO2011159824A1 Composition and method for treating overactive bladder
12/22/2011	WO2011159821A1 Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation
12/22/2011	WO2011159794A1 Deuterated hiv attachment inhibitors
12/22/2011	WO2011159785A1 Novel compounds as cannabinoid receptor ligands
12/22/2011	WO2011159781A2 Bitter taste modulators
12/22/2011	WO2011159771A2 Compositions and methods for treating cancer
12/22/2011	WO2011159769A2 Indane estrogen receptor modulators and uses thereof
12/22/2011	WO2011159762A1 Methods of limiting microvascular damage following acute myocardial ischemia
12/22/2011	WO2011159760A1 Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
12/22/2011	WO2011159717A1 Inhibition of pro-inflammatory cytokine induced response
12/22/2011	WO2011159706A1 Ranolazine for use for the treatment of pulmonary hypertension
12/22/2011	WO2011159693A2 Oral treatment of digital ischemic lesions
12/22/2011	WO2011159634A1 Triheptanoin diet for adult polyglucosan body disease (apbd) treatment
12/22/2011	WO2011159632A1 Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye
12/22/2011	WO2011159626A1 Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
12/22/2011	WO2011159553A1 Heterocyclic fused phenanthrolinone m1 receptor positive allosteric modulators
12/22/2011	WO2011159550A2 Lysophosphatidic acid receptor antagonist and uses thereof
12/22/2011	WO2011159491A2 Controlled release levetiracetam formulations
12/22/2011	WO2011159471A2 Linked purine pterin hppk inhibitors useful as antibacterial agents
12/22/2011	WO2011159302A1 Arylindenopyrimidines for treating neurodegenerative and movement disorders while minimizing cardiac toxicity
12/22/2011	WO2011159297A1 Gpr120 receptor agonists and uses thereof
12/22/2011	WO2011159137A2 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient
12/22/2011	WO2011159129A2 Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients
12/22/2011	WO2011159124A2 Novel benzoxazole derivative having inhibitory activity against interleukin-6, preparation method thereof, and pharmaceutical composition containing same
12/22/2011	WO2011159100A2 Anti-cancer pharmaceutical composition
12/22/2011	WO2011159067A2 Thiazole derivatives as sglt2 inhibitors and pharmaceutical composition comprising same
12/22/2011	WO2011158933A1 Agent for treating renal fibrosis
12/22/2011	WO2011158931A1 Useful salts of indazole derivative
12/22/2011	WO2011158924A1 Inhibitor of expression of dominant allele
12/22/2011	WO2011158904A1 Therapeutic agent for inflammatory diseases containing adenosine n1-oxide as active ingredient
12/22/2011	WO2011158880A1 Crystal of amide compound
12/22/2011	WO2011158870A1 Controlled release nucleated tablet
12/22/2011	WO2011158864A1 Retinol-modified collagen, method for producing same, and external composition for skin containing same
12/22/2011	WO2011158833A1 Agent for treating hcv infection
12/22/2011	WO2011158806A1 Process for production of hematopoietic stem cell
12/22/2011	WO2011158655A1 Use with utilization of soluble klotho-, fgf23- and fgfr-complex formation mechanism in calcified tissue
12/22/2011	WO2011158388A1 Sialic acid-containing sugar chain complex and method for producing same, anti-influenza virus agent and filter
12/22/2011	WO2011158334A1 Food and orally-administered agent for skin whitening containing zederone or zederone analogue as active ingredient
12/22/2011	WO2011158255A1 Process for preparation of stable imatintb mesylate alpha form

1 ... 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 ... 7860